10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BNTC (Benitec) Stock Analysis
Buy, Hold or Sell?

Let's analyze Benitec together

I guess you are interested in Benitec Biopharma Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Benitec’s Financial Insights
  • 📈 Technical Analysis (TA) – Benitec’s Price Targets

I'm going to help you getting a better view of Benitec Biopharma Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Benitec Biopharma Ltd ADR

I send you an email if I find something interesting about Benitec Biopharma Ltd ADR.

1. Quick Overview

1.1. Quick analysis of Benitec (30 sec.)










1.2. What can you expect buying and holding a share of Benitec? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.69
Expected worth in 1 year
$4.20
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$1.51
Return On Investment
9.5%

For what price can you sell your share?

Current Price per Share
$15.90
Expected price per share
$14.20 - $17.15
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Benitec (5 min.)




Live pricePrice per Share (EOD)
$15.90
Intrinsic Value Per Share
$-9.05 - $-4.90
Total Value Per Share
$-6.36 - $-2.21

2.2. Growth of Benitec (5 min.)




Is Benitec growing?

Current yearPrevious yearGrowGrow %
How rich?$97.2m$15.7m$62.4m79.9%

How much money is Benitec making?

Current yearPrevious yearGrowGrow %
Making money-$9m-$3.5m-$5.4m-60.8%
Net Profit Margin-726.0%-17,829.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Benitec (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#326 / 844

Most Revenue
#576 / 844

Most Profit
#503 / 844

Most Efficient
#622 / 844
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Benitec?

Welcome investor! Benitec's management wants to use your money to grow the business. In return you get a share of Benitec.

First you should know what it really means to hold a share of Benitec. And how you can make/lose money.

Speculation

The Price per Share of Benitec is $15.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Benitec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Benitec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.69. Based on the TTM, the Book Value Change Per Share is $0.38 per quarter. Based on the YOY, the Book Value Change Per Share is $0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Benitec.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.45-2.8%-0.27-1.7%-0.13-0.8%-0.18-1.1%-0.15-0.9%-0.11-0.7%
Usd Book Value Change Per Share0.161.0%0.382.4%0.291.8%0.221.4%0.120.8%0.060.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.161.0%0.382.4%0.291.8%0.221.4%0.120.8%0.060.4%
Usd Price Per Share11.70-11.63-4.62-5.50-4.72-3.73-
Price to Earnings Ratio-6.56--12.39--9.29--7.39--8.37--19.40-
Price-to-Total Gains Ratio73.46-17.35--14.73-0.54--10.38--16.05-
Price to Book Ratio4.35-4.91-9.55-9.08-11.27-15.36-
Price-to-Total Gains Ratio73.46-17.35--14.73-0.54--10.38--16.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.9
Number of shares62
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.380.12
Usd Total Gains Per Share0.380.12
Gains per Quarter (62 shares)23.477.54
Gains per Year (62 shares)93.8830.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10948403020
2018817806050
3028227209180
403763660121110
504694600151140
605635540181170
706576480211200
807517420241230
908458360272260
1009399300302290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%5.035.00.012.5%7.045.00.013.5%
Book Value Change Per Share3.01.00.075.0%6.06.00.050.0%8.012.00.040.0%15.024.01.037.5%18.025.09.034.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.052.00.0%
Total Gains per Share3.01.00.075.0%6.06.00.050.0%8.012.00.040.0%15.024.01.037.5%18.025.09.034.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Benitec Biopharma Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1590.379-58%0.292-45%0.218-27%0.122+31%0.056+185%
Book Value Per Share--2.6872.425+11%0.599+349%1.067+152%0.752+257%0.550+388%
Current Ratio--54.67127.491+99%6.030+807%12.287+345%10.791+407%12.372+342%
Debt To Asset Ratio--0.0230.051-54%0.195-88%0.233-90%0.218-89%0.150-85%
Debt To Equity Ratio--0.0240.054-56%0.251-91%1.969-99%1.300-98%0.695-97%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--519095470.700451592833.253+15%136368605.302+281%199343121.731+160%159365852.227+226%118463282.193+338%
Eps---0.446-0.274-39%-0.135-70%-0.177-60%-0.146-67%-0.108-76%
Ev To Ebitda Ratio---6.823-14.182+108%-10.593+55%-8.523+25%-9.447+38%-4.563-33%
Ev To Sales Ratio--233.406233.4060%9256.642-97%1682.667-86%10307.448-98%4370.643-95%
Free Cash Flow Per Share---0.226-0.179-21%-0.122-46%-0.137-39%-0.118-48%-0.087-62%
Free Cash Flow To Equity Per Share---0.1560.328-148%0.301-152%0.205-176%0.167-193%0.079-298%
Gross Profit Margin--1.0001.0000%1.009-1%1.0030%1.0020%0.985+2%
Intrinsic Value_10Y_max---4.900----------
Intrinsic Value_10Y_min---9.050----------
Intrinsic Value_1Y_max---0.369----------
Intrinsic Value_1Y_min---0.614----------
Intrinsic Value_3Y_max---1.202----------
Intrinsic Value_3Y_min---2.110----------
Intrinsic Value_5Y_max---2.147----------
Intrinsic Value_5Y_min---3.884----------
Market Cap417382457.100-2%423648470.700374653146.953+13%121353949.402+249%167501581.231+153%137756926.867+208%104762723.304+304%
Net Profit Margin---29.041-7.260-75%-178.292+514%-156.138+438%-700.804+2313%-362.124+1147%
Operating Margin---33.709-8.427-75%-178.125+428%-157.404+367%-701.621+1981%-364.285+981%
Operating Ratio--31.3927.848+300%176.417-82%158.050-80%692.051-95%358.544-91%
Pb Ratio5.917+26%4.3544.909-11%9.555-54%9.083-52%11.267-61%15.356-72%
Pe Ratio-8.914-36%-6.559-12.386+89%-9.292+42%-7.394+13%-8.370+28%-19.403+196%
Price Per Share15.900+26%11.70011.633+1%4.623+153%5.501+113%4.720+148%3.727+214%
Price To Free Cash Flow Ratio-17.551-36%-12.915-21.111+63%-10.583-18%-10.759-17%-11.139-14%-12.749-1%
Price To Total Gains Ratio99.835+26%73.46317.355+323%-14.730+120%0.538+13564%-10.377+114%-16.048+122%
Quick Ratio--54.26027.312+99%5.949+812%12.127+347%10.558+414%11.275+381%
Return On Assets---0.162-0.104-36%-0.229+41%-0.305+88%-0.322+98%-0.376+132%
Return On Equity---0.166-0.109-34%-0.295+78%-2.216+1235%-1.533+824%-1.003+505%
Total Gains Per Share--0.1590.379-58%0.292-45%0.218-27%0.122+31%0.056+185%
Usd Book Value--97295000.00078156422.000+24%15724085.400+519%32842247.067+196%22638004.360+330%15895360.935+512%
Usd Book Value Change Per Share--0.1590.379-58%0.292-45%0.218-27%0.122+31%0.056+185%
Usd Book Value Per Share--2.6872.425+11%0.599+349%1.067+152%0.752+257%0.550+388%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--519095470.700451592833.253+15%136368605.302+281%199343121.731+160%159365852.227+226%118463282.193+338%
Usd Eps---0.446-0.274-39%-0.135-70%-0.177-60%-0.146-67%-0.108-76%
Usd Free Cash Flow---8201000.000-5499059.400-33%-3201331.163-61%-3878236.088-53%-3270811.268-60%-2364213.239-71%
Usd Free Cash Flow Per Share---0.226-0.179-21%-0.122-46%-0.137-39%-0.118-48%-0.087-62%
Usd Free Cash Flow To Equity Per Share---0.1560.328-148%0.301-152%0.205-176%0.167-193%0.079-298%
Usd Market Cap417382457.100-2%423648470.700374653146.953+13%121353949.402+249%167501581.231+153%137756926.867+208%104762723.304+304%
Usd Price Per Share15.900+26%11.70011.633+1%4.623+153%5.501+113%4.720+148%3.727+214%
Usd Profit---16147000.000-9038611.100-44%-3543237.900-78%-5273216.467-67%-4203394.780-74%-2704600.216-83%
Usd Revenue--556000.000139000.000+300%977.400+56786%76361.233+628%50998.328+990%248446.613+124%
Usd Total Gains Per Share--0.1590.379-58%0.292-45%0.218-27%0.122+31%0.056+185%
 EOD+4 -4MRQTTM+16 -20YOY+22 -163Y+22 -165Y+26 -1210Y+26 -12

3.3 Fundamental Score

Let's check the fundamental score of Benitec Biopharma Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.914
Price to Book Ratio (EOD)Between0-15.917
Net Profit Margin (MRQ)Greater than0-29.041
Operating Margin (MRQ)Greater than0-33.709
Quick Ratio (MRQ)Greater than154.260
Current Ratio (MRQ)Greater than154.671
Debt to Asset Ratio (MRQ)Less than10.023
Debt to Equity Ratio (MRQ)Less than10.024
Return on Equity (MRQ)Greater than0.15-0.166
Return on Assets (MRQ)Greater than0.05-0.162
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Benitec Biopharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.649
Ma 20Greater thanMa 5014.099
Ma 50Greater thanMa 10013.490
Ma 100Greater thanMa 20013.476
OpenGreater thanClose15.080
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Benitec Biopharma Ltd ADR

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.

Fundamental data was last updated by Penke on 2025-09-25 08:05:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Benitec earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • A Net Profit Margin of -2,904.1% means that $-29.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Benitec Biopharma Ltd ADR:

  • The MRQ is -2,904.1%. The company is making a huge loss. -2
  • The TTM is -726.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,904.1%TTM-726.0%-2,178.1%
TTM-726.0%YOY-17,829.2%+17,103.1%
TTM-726.0%5Y-70,080.4%+69,354.4%
5Y-70,080.4%10Y-36,212.4%-33,868.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,904.1%-70.7%-2,833.4%
TTM-726.0%-161.7%-564.3%
YOY-17,829.2%-189.8%-17,639.4%
3Y-15,613.8%-262.6%-15,351.2%
5Y-70,080.4%-338.6%-69,741.8%
10Y-36,212.4%-473.1%-35,739.3%
4.3.1.2. Return on Assets

Shows how efficient Benitec is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • -16.2% Return on Assets means that Benitec generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Benitec Biopharma Ltd ADR:

  • The MRQ is -16.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.2%TTM-10.4%-5.8%
TTM-10.4%YOY-22.9%+12.4%
TTM-10.4%5Y-32.2%+21.7%
5Y-32.2%10Y-37.6%+5.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.2%-11.9%-4.3%
TTM-10.4%-11.9%+1.5%
YOY-22.9%-11.2%-11.7%
3Y-30.5%-12.0%-18.5%
5Y-32.2%-12.0%-20.2%
10Y-37.6%-14.0%-23.6%
4.3.1.3. Return on Equity

Shows how efficient Benitec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • -16.6% Return on Equity means Benitec generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Benitec Biopharma Ltd ADR:

  • The MRQ is -16.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.6%TTM-10.9%-5.7%
TTM-10.9%YOY-29.5%+18.5%
TTM-10.9%5Y-153.3%+142.3%
5Y-153.3%10Y-100.3%-53.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.6%-14.2%-2.4%
TTM-10.9%-14.8%+3.9%
YOY-29.5%-15.3%-14.2%
3Y-221.6%-16.8%-204.8%
5Y-153.3%-17.4%-135.9%
10Y-100.3%-19.8%-80.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Benitec Biopharma Ltd ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Benitec is operating .

  • Measures how much profit Benitec makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • An Operating Margin of -3,370.9% means the company generated $-33.71  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Benitec Biopharma Ltd ADR:

  • The MRQ is -3,370.9%. The company is operating very inefficient. -2
  • The TTM is -842.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3,370.9%TTM-842.7%-2,528.1%
TTM-842.7%YOY-17,812.5%+16,969.8%
TTM-842.7%5Y-70,162.1%+69,319.4%
5Y-70,162.1%10Y-36,428.5%-33,733.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,370.9%-153.1%-3,217.8%
TTM-842.7%-265.6%-577.1%
YOY-17,812.5%-249.5%-17,563.0%
3Y-15,740.4%-248.8%-15,491.6%
5Y-70,162.1%-331.9%-69,830.2%
10Y-36,428.5%-489.0%-35,939.5%
4.3.2.2. Operating Ratio

Measures how efficient Benitec is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 31.39 means that the operating costs are $31.39 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 31.392. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.848. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ31.392TTM7.848+23.544
TTM7.848YOY176.417-168.569
TTM7.8485Y692.051-684.203
5Y692.05110Y358.544+333.507
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ31.3921.861+29.531
TTM7.8482.793+5.055
YOY176.4172.852+173.565
3Y158.0503.559+154.491
5Y692.0514.633+687.418
10Y358.5446.269+352.275
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Benitec Biopharma Ltd ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Benitec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 54.67 means the company has $54.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 54.671. The company is very able to pay all its short-term debts. +2
  • The TTM is 27.491. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ54.671TTM27.491+27.180
TTM27.491YOY6.030+21.462
TTM27.4915Y10.791+16.700
5Y10.79110Y12.372-1.581
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ54.6713.431+51.240
TTM27.4913.644+23.847
YOY6.0304.060+1.970
3Y12.2874.456+7.831
5Y10.7915.742+5.049
10Y12.3726.132+6.240
4.4.3.2. Quick Ratio

Measures if Benitec is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • A Quick Ratio of 54.26 means the company can pay off $54.26 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 54.260. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 27.312. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ54.260TTM27.312+26.948
TTM27.312YOY5.949+21.363
TTM27.3125Y10.558+16.754
5Y10.55810Y11.275-0.717
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ54.2602.911+51.349
TTM27.3123.133+24.179
YOY5.9493.831+2.118
3Y12.1274.337+7.790
5Y10.5585.697+4.861
10Y11.2756.537+4.738
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Benitec Biopharma Ltd ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Benitec assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Benitec to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.02 means that Benitec assets are financed with 2.3% credit (debt) and the remaining percentage (100% - 2.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.023. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.051. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.023TTM0.051-0.027
TTM0.051YOY0.195-0.144
TTM0.0515Y0.218-0.168
5Y0.21810Y0.150+0.068
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0230.344-0.321
TTM0.0510.364-0.313
YOY0.1950.335-0.140
3Y0.2330.344-0.111
5Y0.2180.349-0.131
10Y0.1500.379-0.229
4.5.4.2. Debt to Equity Ratio

Measures if Benitec is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • A Debt to Equity ratio of 2.4% means that company has $0.02 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.024. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.054. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.024TTM0.054-0.030
TTM0.054YOY0.251-0.197
TTM0.0545Y1.300-1.246
5Y1.30010Y0.695+0.605
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0240.401-0.377
TTM0.0540.445-0.391
YOY0.2510.435-0.184
3Y1.9690.471+1.498
5Y1.3000.467+0.833
10Y0.6950.517+0.178
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Benitec generates.

  • Above 15 is considered overpriced but always compare Benitec to the Biotechnology industry mean.
  • A PE ratio of -6.56 means the investor is paying $-6.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is -8.914. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.559. Based on the earnings, the company is expensive. -2
  • The TTM is -12.386. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.914MRQ-6.559-2.355
MRQ-6.559TTM-12.386+5.826
TTM-12.386YOY-9.292-3.093
TTM-12.3865Y-8.370-4.016
5Y-8.37010Y-19.403+11.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.914-2.840-6.074
MRQ-6.559-2.312-4.247
TTM-12.386-2.654-9.732
YOY-9.292-3.619-5.673
3Y-7.394-3.736-3.658
5Y-8.370-5.803-2.567
10Y-19.403-6.948-12.455
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is -17.551. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.915. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -21.111. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.551MRQ-12.915-4.636
MRQ-12.915TTM-21.111+8.196
TTM-21.111YOY-10.583-10.528
TTM-21.1115Y-11.139-9.971
5Y-11.13910Y-12.749+1.610
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-17.551-3.555-13.996
MRQ-12.915-2.911-10.004
TTM-21.111-3.693-17.418
YOY-10.583-4.195-6.388
3Y-10.759-5.149-5.610
5Y-11.139-8.425-2.714
10Y-12.749-9.923-2.826
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Benitec is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.35 means the investor is paying $4.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is 5.917. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.354. Based on the equity, the company is fair priced.
  • The TTM is 4.909. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.917MRQ4.354+1.563
MRQ4.354TTM4.909-0.555
TTM4.909YOY9.555-4.646
TTM4.9095Y11.267-6.358
5Y11.26710Y15.356-4.089
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.9172.487+3.430
MRQ4.3542.063+2.291
TTM4.9092.237+2.672
YOY9.5552.444+7.111
3Y9.0832.657+6.426
5Y11.2673.804+7.463
10Y15.3564.517+10.839
4.6.2. Total Gains per Share

2.4. Latest News of Benitec Biopharma Ltd ADR

Does Benitec Biopharma Ltd ADR still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Benitec Biopharma Ltd ADR to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-22
23:27
Benitec Biopharma files $200M mixed securities shelfRead
2025-09-22
22:05
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational UpdateRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Benitec Biopharma Ltd ADR.

4.8.1. Institutions holding Benitec Biopharma Ltd ADR

Institutions are holding 91.046% of the shares of Benitec Biopharma Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Suvretta Capital Management, LLC37.62413.4835987650600
2025-06-30HHG PLC11.05810.01662902794-16156-0.5535
2025-06-30Franklin Resources Inc10.2910.00842701443-159283-5.5679
2025-06-30Adage Capital Partners Gp LLC7.51420.0389197252400
2025-06-30Vanguard Group Inc3.6920.0002969166642132196.3502
2025-06-30Nantahala Capital Management, LLC3.19270.384283809500
2025-06-30BlackRock Inc2.73780.0002718690534264289.6902
2025-06-30Geode Capital Management, LLC1.58170.000341521118139177.5772
2025-06-30Schonfeld Strategic Advisors LLC0.9920.0207260417-1347-0.5146
2025-06-30SILVERARC CAPITAL MANAGEMENT, LLC0.96470.546425323432341.2936
2025-06-30State Street Corp0.61360.0001161073139883660.1369
2025-06-30Awm Investment Company Inc0.52560.18113797700
2025-06-30Northern Trust Corp0.48120.000212632280445175.3493
2025-06-30Ameriprise Financial Inc0.41880.000310992575507219.3823
2025-06-30ExodusPoint Capital Management, LP0.2910.007876379-6819-8.1961
2025-06-30Simplify Asset Management Inc.0.26350.040769173-7562-9.8547
2025-06-30MYDA Advisors LLC0.23660.127621161011619.4538
2025-06-30Lion Point Capital, LP0.23624.92516200000
2025-06-30Longaeva Partners L.P.0.19810.124251997-28003-35.0038
2025-06-30Charles Schwab Investment Management Inc0.17250.000145274452740
Total 83.08549.905921810316+1493076+6.8%

4.9.2. Funds holding Benitec Biopharma Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-08-31Franklin Biotechnology Discv A(acc)USD5.69841.3872149586900
2025-06-30HBM Healthcare Investments AG Ord4.53960.6815119166900
2025-07-31Franklin Biotechnology Discovery A4.38171.72761150214-55287-4.5862
2025-07-31Vanguard Total Stock Mkt Idx Inv1.88610.0003495117-10906-2.1552
2025-06-30Janus Henderson Hrzn Biotec E2 USD1.61620.9375424247-16156-3.6685
2025-08-31iShares Russell 2000 ETF1.23460.006532408200
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.89110.0032233909-98520-29.6364
2025-06-30Fidelity Small Cap Index0.55390.00671454091454090
2025-08-31iShares Russell 2000 Growth ETF0.46860.013212299800
2025-07-31Fidelity Extended Market Index0.440.0032115500-950-0.8158
2025-06-30MEDICAL BioHealth EUR Acc0.34610.1566908583700068.6992
2025-07-31Vanguard Russell 2000 ETF0.26360.00669196-4481-6.082
2025-07-31Simplify Health Care ETF0.25740.597367581-1592-2.3015
2025-08-31State St Russell Sm Cap® Indx SL Cl I0.19470.0075110000
2025-06-30Extended Equity Market Fund K0.16430.003543121-861-1.9576
2025-05-31RIM Global Bioscience EUR0.16410.82494306400
2025-07-31Fidelity Total Market Index0.15140.000439732-85-0.2135
2025-07-31Schwab Small Cap Index0.13820.00613627400
2025-06-30NT R2000 Index Fund - NL0.13340.006635017350170
2025-08-31iShares Micro-Cap ETF0.12510.0483283600
Total 23.64856.42336207793+28588+0.5%

5.3. Insider Transactions

Insiders are holding 3.115% of the shares of Benitec Biopharma Ltd ADR.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-03-26Suvretta Capital Management, LBUY90000013
2024-12-23Suvretta Capital Management, LBUY2750210.98
2024-12-03Suvretta Capital Management, LBUY420009.6
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Gross Profit  -590-59-22-81-25-106384278
Depreciation and Amortization  59059228125106-384-278



5.2. Latest Balance Sheet

Balance Sheet of 2025-06-30. All numbers in thousands.

Summary
Total Assets99,592
Total Liabilities2,297
Total Stockholder Equity97,295
 As reported
Total Liabilities 2,297
Total Stockholder Equity+ 97,295
Total Assets = 99,592

Assets

Total Assets99,592
Total Current Assets98,518
Long-term Assets1,074
Total Current Assets
Cash And Cash Equivalents 97,744
Net Receivables 33
Other Current Assets 741
Total Current Assets  (as reported)98,518
Total Current Assets  (calculated)98,518
+/-0
Long-term Assets
Property Plant Equipment 991
Long-term Assets Other 83
Long-term Assets  (as reported)1,074
Long-term Assets  (calculated)1,074
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,802
Long-term Liabilities495
Total Stockholder Equity97,295
Total Current Liabilities
Short-term Debt 708
Accounts payable 1,022
Other Current Liabilities 72
Total Current Liabilities  (as reported)1,802
Total Current Liabilities  (calculated)1,802
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)495
Long-term Liabilities  (calculated)0
+/- 495
Total Stockholder Equity
Common Stock2
Retained Earnings -228,176
Accumulated Other Comprehensive Income -839
Other Stockholders Equity 326,308
Total Stockholder Equity (as reported)97,295
Total Stockholder Equity (calculated)97,295
+/-0
Other
Cash and Short Term Investments 97,744
Common Stock Shares Outstanding 36,209
Liabilities and Stockholders Equity 99,592
Net Debt -96,895
Short Long Term Debt Total 849



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
> Total Assets 
0
0
0
1,605
0
0
0
24,027
0
24,819
0
19,574
0
20,596
20,726
14,853
15,785
14,362
19,243
17,418
16,092
13,848
11,447
15,675
21,862
21,316
646
19,207
308
16,306
13,580
11,587
8,916
15,512
13,428
21,379
17,836
14,014
10,064
5,973
18,115
11,905
8,220
4,464
27,053
21,353
14,999
52,210
68,774
79,068
105,209
99,592
99,592105,20979,06868,77452,21014,99921,35327,0534,4648,22011,90518,1155,97310,06414,01417,83621,37913,42815,5128,91611,58713,58016,30630819,20764621,31621,86215,67511,44713,84816,09217,41819,24314,36215,78514,85320,72620,596019,574024,819024,0270001,605000
   > Total Current Assets 
0
0
0
0
0
0
0
23,598
0
24,477
0
19,224
0
20,243
20,269
14,476
15,415
13,945
18,846
17,030
15,710
13,400
11,048
15,349
21,597
21,057
630
18,729
21,920
15,346
12,728
10,809
8,056
14,383
12,407
20,608
16,372
12,672
8,841
4,820
17,081
10,975
7,395
3,729
26,412
20,796
14,366
51,674
68,335
78,713
104,010
98,518
98,518104,01078,71368,33551,67414,36620,79626,4123,7297,39510,97517,0814,8208,84112,67216,37220,60812,40714,3838,05610,80912,72815,34621,92018,72963021,05721,59715,34911,04813,40015,71017,03018,84613,94515,41514,47620,26920,243019,224024,477023,5980000000
       Cash And Cash Equivalents 
0
0
0
1,455
0
0
0
20,512
0
21,948
0
16,711
0
16,574
15,223
13,614
10,216
8,840
15,007
13,352
11,532
8,011
8,085
11,816
16,750
16,332
528
15,695
260
13,762
11,400
9,801
7,450
14,010
11,988
19,769
15,727
12,329
8,630
4,062
16,534
10,537
6,551
2,477
25,864
20,374
14,156
50,866
67,841
78,283
103,583
97,744
97,744103,58378,28367,84150,86614,15620,37425,8642,4776,55110,53716,5344,0628,63012,32915,72719,76911,98814,0107,4509,80111,40013,76226015,69552816,33216,75011,8168,0858,01111,53213,35215,0078,84010,21613,61415,22316,574016,711021,948020,5120001,455000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,456
0
21
0
72
77
77
78
55
33
22
3
3
0
127
0
23
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
0
0
0
0
000063000000000000000012301270332233557877777202101,4560000000000000
       Net Receivables 
0
0
0
0
0
0
0
239
0
60
0
312
0
28
25
1,630
5,925
5,679
4,444
3,495
3,979
4,873
2,429
3,126
4,278
4,171
85
5,245
1,326
928
818
59
18
21
10
25
3
5
5
3
3
68
56
55
53
53
53
229
4
2
3
33
333242295353535556683355325102118598189281,3265,245854,1714,2783,1262,4294,8733,9793,4954,4445,6795,9251,6302528031206002390000000
       Other Current Assets 
0
0
0
28
0
0
0
2,969
0
5,486
0
2,325
0
2,184
2,265
132
175
255
436
293
121
920
502
771
72
552
4
501
133
632
509
949
588
352
409
814
642
338
206
755
544
370
788
1,184
482
355
157
516
490
428
424
741
7414244284905161573554821,1847883705447552063386428144093525889495096321335014552727715029201212934362551751322,2652,18402,32505,48602,96900028000
   > Long-term Assets 
0
0
0
0
0
0
0
429
0
342
0
350
0
354
457
378
370
417
397
387
382
449
398
326
0
259
0
478
0
960
852
778
860
1,129
1,021
771
1,464
1,342
1,223
1,153
1,034
930
825
735
641
527
633
536
439
355
1,199
1,074
1,0741,1993554395366335276417358259301,0341,1531,2231,3421,4647711,0211,1298607788529600478025903263984493823873974173703784573540350034204290000000
       Property Plant Equipment 
0
0
0
26
0
0
0
429
0
342
0
350
0
354
457
378
325
374
352
342
336
321
273
234
198
193
670
469
1,358
951
843
769
851
910
815
577
1,270
1,156
1,042
993
890
789
695
613
531
451
539
449
358
288
1,109
991
9911,1092883584495394515316136957898909931,0421,1561,2705778159108517698439511,35846967019319823427332133634235237432537845735403500342042900026000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45
0
0
0
56
0
67
0
13
0
13
0
9
9
9
219
206
194
194
186
181
160
144
141
0
122
0
30
0
0
0
0
0
0
000000300122014114416018118619419420621999901301306705600045000000000000000000
> Total Liabilities 
0
0
0
1,018
0
0
0
1,546
0
588
0
1,259
0
730
1,706
786
732
1,005
897
891
1,361
1,420
1,316
1,906
1,553
1,514
89
2,637
20
1,083
1,244
1,349
1,180
887
2,498
1,369
2,361
3,178
2,544
3,091
3,502
2,911
3,507
4,262
4,745
5,883
3,499
4,962
4,594
3,127
7,639
2,297
2,2977,6393,1274,5944,9623,4995,8834,7454,2623,5072,9113,5023,0912,5443,1782,3611,3692,4988871,1801,3491,2441,083202,637891,5141,5531,9061,3161,4201,3618918971,0057327861,70673001,259058801,5460001,018000
   > Total Current Liabilities 
0
0
0
1,018
0
0
0
1,546
0
588
0
1,259
0
730
1,693
773
710
985
871
865
1,333
1,390
1,281
1,871
1,547
1,508
89
2,637
1,080
756
981
1,136
1,019
779
2,444
1,369
1,601
2,480
1,909
2,532
3,011
2,489
3,153
3,978
4,534
5,746
3,437
4,924
4,553
3,089
7,026
1,802
1,8027,0263,0894,5534,9243,4375,7464,5343,9783,1532,4893,0112,5321,9092,4801,6011,3692,4447791,0191,1369817561,0802,637891,5081,5471,8711,2811,3901,3338658719857107731,69373001,259058801,5460001,018000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
181
187
192
396
406
416
426
388
426
464
504
516
526
269
550
560
572
584
568
422
274
692
708
70869227442256858457256055026952651650446442638842641640639619218718100000000000000000000000000000
       Accounts payable 
0
0
0
256
0
0
0
716
0
197
0
583
0
384
1,391
402
212
467
227
134
541
641
158
426
251
244
49
1,474
142
99
288
282
299
87
1,640
274
323
682
100
422
608
531
635
1,140
1,528
2,619
815
1,351
903
593
433
1,022
1,0224335939031,3518152,6191,5281,1406355316084221006823232741,64087299282288991421,474492442514261586415411342274672124021,391384058301970716000256000
       Other Current Liabilities 
0
0
0
762
0
0
0
830
0
391
0
676
0
347
310
371
498
518
644
731
792
749
1,123
1,445
1,155
1,264
34
1,163
453
475
506
662
324
286
388
669
890
1,372
1,345
1,606
1,887
1,432
2,249
2,288
2,446
2,555
2,409
3,143
3,228
2,222
5,901
72
725,9012,2223,2283,1432,4092,5552,4462,2882,2491,4321,8871,6061,3451,3728906693882863246625064754531,163341,2641,1551,4451,123749792731644518498371310347067603910830000762000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
22
19
25
27
28
30
35
35
0
6
0
0
0
327
263
213
161
108
54
0
760
698
635
559
491
422
354
284
211
137
62
38
41
38
613
495
49561338413862137211284354422491559635698760054108161213263327000603535302827251922131300000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
467
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000046700000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
13
22
20
25
26
29
30
16
14
7
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000271416302926252022131400000000000000
> Total Stockholder Equity
0
0
0
587
0
0
0
22,481
0
24,231
0
18,314
0
19,866
19,020
14,067
15,053
13,358
18,346
16,526
14,731
12,429
10,130
13,769
20,308
19,801
557
16,570
287
15,223
12,336
10,238
7,736
14,625
10,930
20,010
15,475
10,836
7,520
2,882
14,613
8,994
4,713
202
22,308
15,470
11,500
47,248
64,180
75,941
97,570
97,295
97,29597,57075,94164,18047,24811,50015,47022,3082024,7138,99414,6132,8827,52010,83615,47520,01010,93014,6257,73610,23812,33615,22328716,57055719,80120,30813,76910,13012,42914,73116,52618,34613,35815,05314,06719,02019,866018,314024,231022,481000587000
   Common Stock
0
0
0
82,127
0
0
0
122,047
0
105,990
0
99,427
0
107,497
113,064
110,256
112,606
108,135
119,035
119,556
122,062
121,353
119,392
120,537
118,543
115,583
164,087
114,917
166,709
116,709
1
1
1
4
5
1
1
1
1
1
3
3
3
0
0
0
0
1
1
2
2
2
2221100003331111154111116,709166,709114,917164,087115,583118,543120,537119,392121,353122,062119,556119,035108,135112,606110,256113,064107,497099,4270105,9900122,04700082,127000
   Retained Earnings Total Equity00000000000000000-126,116-122,2070-116,6360000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
1,919
0
1,141
0
1,563
0
1,898
1,772
1,915
1,364
1,079
1,204
1,286
1,429
1,299
1,325
1,096
0
806
0
582
0
319
-2,733
-1,953
-1,775
-1,567
-1,591
-1,455
-1,216
-1,273
-1,506
-1,245
-738
-898
-853
-830
-780
-952
-835
-892
-993
-688
-716
-839
-839-716-688-993-892-835-952-780-830-853-898-738-1,245-1,506-1,273-1,216-1,455-1,591-1,567-1,775-1,953-2,7333190582080601,0961,3251,2991,4291,2861,2041,0791,3641,9151,7721,89801,56301,14101,9190000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,826
0
138,395
138,632
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000138,632138,3950128,8260000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
517
0
381
0
0
0
0
0
0
2,086
826
0
831
127,327
455
0
128,897
128,827
128,850
138,395
138,632
151,583
151,854
152,093
152,285
152,454
168,768
168,720
168,791
168,921
196,931
197,063
197,255
238,398
260,490
279,302
310,313
326,308
326,308310,313279,302260,490238,398197,255197,063196,931168,921168,791168,720168,768152,454152,285152,093151,854151,583138,632138,395128,850128,827128,8970455127,32783108262,086000000381051700000000000000



5.4. Balance Sheets

All numbers in thousands.




5.5. Cash Flows

All numbers in thousands.




5.6. Income Statements

All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2025-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue-
Cost of Revenue-396
Gross Profit-396-396
 
Operating Income (+$)
Gross Profit-396
Operating Expense-41,369
Operating Income-41,765-41,765
 
Operating Expense (+$)
Research Development18,332
Selling General Administrative23,433
Selling And Marketing Expenses-
Operating Expense41,36941,765
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-41,765
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-37,917-45,613
EBIT - interestExpense = -41,834
-37,917
-37,917
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-41,834-37,917
Earnings Before Interest and Taxes (EBITDA)-41,765
 
After tax Income (+$)
Income Before Tax-37,917
Tax Provision--
Net Income From Continuing Ops--37,917
Net Income-37,917
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses41,765
Total Other Income/Expenses Net3,8480
 

Technical Analysis of Benitec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Benitec. The general trend of Benitec is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Benitec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Benitec Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Benitec Biopharma Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 16.90 < 17.15.

The bearish price targets are: 14.33 > 14.30 > 14.20.

Know someone who trades $BNTC? Share this with them.👇

Benitec Biopharma Ltd ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Benitec Biopharma Ltd ADR. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Benitec Biopharma Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Benitec Biopharma Ltd ADR. The current macd is 0.45661652.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Benitec price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Benitec. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Benitec price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Benitec Biopharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartBenitec Biopharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Benitec Biopharma Ltd ADR. The current adx is 17.48.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Benitec shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Benitec Biopharma Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Benitec Biopharma Ltd ADR. The current sar is 13.95.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Benitec Biopharma Ltd ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Benitec Biopharma Ltd ADR. The current rsi is 74.65. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Benitec Biopharma Ltd ADR Daily Relative Strength Index (RSI) ChartBenitec Biopharma Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Benitec Biopharma Ltd ADR. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Benitec price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Benitec Biopharma Ltd ADR Daily Stochastic Oscillator ChartBenitec Biopharma Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Benitec Biopharma Ltd ADR. The current cci is 248.38.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Benitec Biopharma Ltd ADR Daily Commodity Channel Index (CCI) ChartBenitec Biopharma Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Benitec Biopharma Ltd ADR. The current cmo is 64.68.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Benitec Biopharma Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartBenitec Biopharma Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Benitec Biopharma Ltd ADR. The current willr is -10.92150171.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Benitec Biopharma Ltd ADR Daily Williams %R ChartBenitec Biopharma Ltd ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Benitec Biopharma Ltd ADR. The current atr is 0.67295996.

Benitec Biopharma Ltd ADR Daily Average True Range (ATR) ChartBenitec Biopharma Ltd ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Benitec Biopharma Ltd ADR. The current obv is 2,990,040.

Benitec Biopharma Ltd ADR Daily On-Balance Volume (OBV) ChartBenitec Biopharma Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Benitec Biopharma Ltd ADR. The current mfi is 87.22.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Benitec Biopharma Ltd ADR Daily Money Flow Index (MFI) ChartBenitec Biopharma Ltd ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Benitec Biopharma Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-07-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-08-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-08-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-08-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-10-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-10-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Benitec Biopharma Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Benitec Biopharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.649
Ma 20Greater thanMa 5014.099
Ma 50Greater thanMa 10013.490
Ma 100Greater thanMa 20013.476
OpenGreater thanClose15.080
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Benitec with someone you think should read this too:
  • Are you bullish or bearish on Benitec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Benitec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Benitec Biopharma Ltd ADR

I send you an email if I find something interesting about Benitec Biopharma Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Benitec Biopharma Ltd ADR.

Receive notifications about Benitec Biopharma Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.